Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SANTO is a Kazakhstan-based pharmaceutical manufacturer operating as JSC Khimfarm under the trade name SANTO Member of Polpharma Group. The company develops, manufactures, and supplies affordable prescription and consumer medicines, with a portfolio of more than 200-240 generic and some original products spanning 12 therapeutic categories. SANTO is one of the leaders in Kazakhstan’s pharmaceutical market and serves Kazakhstan and broader Central Asian export markets. Its operations include large-scale GMP-certified manufacturing for solid oral products, injectables, infusion solutions, antibiotic powders, and oral liquids. As part of Polpharma Group, SANTO functions primarily as a commercial-stage regional pharma manufacturing and distribution business rather than a novel-drug biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SANTO.